Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,240 | -113,773 | -78,402 | -23,678 | -88,180 |
| Depreciation Amortization | 4,710 | 3,172 | 1,617 | 467 | 3,830 |
| Accounts payable and accrued liabilities | -526 | 1,235 | 7,094 | -951 | 207 |
| Other Working Capital | 62,891 | 55,605 | 62,278 | 54,132 | 3,300 |
| Other Operating Activity | 19,281 | 10,692 | -834 | 3,607 | 4,213 |
| Operating Cash Flow | $50,116 | $-43,069 | $-8,247 | $33,577 | $-76,630 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,393 | -1,956 | -1,109 | -537 | -2,870 |
| Purchase Of Investment | -557,930 | -400,637 | -361,686 | -328,036 | -179,789 |
| Sale Of Investment | 273,901 | 176,574 | 92,049 | 27,299 | 141,498 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 1 |
| Investing Cash Flow | $-287,422 | $-226,019 | $-270,746 | $-301,274 | $-41,160 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 98,405 | 96,715 | 96,057 | 94,625 | 266,352 |
| Other Financing Activity | -1,386 | -1,386 | -1,386 | -1,386 | 29,968 |
| Financing Cash Flow | $97,019 | $95,329 | $94,671 | $93,239 | $296,320 |
| Beginning Cash Position | 218,910 | 218,910 | 218,910 | 218,910 | 39,850 |
| End Cash Position | 78,623 | 45,151 | 34,588 | 44,452 | 218,370 |
| Net Cash Flow | $-140,287 | $-173,759 | $-184,322 | $-174,458 | $178,520 |
| Free Cash Flow | |||||
| Operating Cash Flow | 50,116 | -43,069 | -8,247 | 33,577 | -76,630 |
| Capital Expenditure | -3,393 | -1,956 | -1,109 | -537 | -2,875 |
| Free Cash Flow | 46,723 | -45,025 | -9,356 | 33,040 | -79,505 |